Government of CanadaPublic Health Agency of Canada / Agence de santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
   



Volume 21, No.3 - 2000
  

 

Public Health Agency of Canada (PHAC)

Elements of Mobility as Predictors of Survival in Elderly Patients with Dementia: Findings from the Canadian Study of Health and Aging

Athanasios Tom Koutsavlis and Christina Wolfson


Volume 21, No. 3 - 2000  


Abstract

In order to identify elements of mobility that predict survival in elderly people with dementia, we conducted a two-year follow-up of a cohort of dementia subjects from the population-based Canadian Study of Health and Aging. There were 749 prevalent cases of Alzheimer's disease and 208 prevalent cases of vascular dementia. Elements of mobility that predicted death during the two-year follow-up period included difficulty in dressing (OR = 2.08, 95% CI: 1.41-3.07), difficulty in getting about (OR = 1.69, 95% CI: 1.18-2.40), history of falls (OR = 1.43, 95% CI: 1.05-1.94), abnormal gait (OR = 1.61, 95% CI: 1.08-2.40) and abnormal motor strength (OR = 1.51, 95% CI: 1.07-2.15). Sociodemographic factors such as older age and male sex were also significant predictors of decreased survival. These associations are potentially useful to clinicians and health professionals by providing prognostic information to supply to families and suggesting areas in which interventions to improve survival might be focused.

Key words: dementia; mobility; predictors; survival


Introduction

Old age is all too commonly a time of impaired neurologic function. In 1978, the annual cost of caring for patients with dementia in the United States, where dementia is the major debilitating condition of more than half the residents of nursing homes, was $12 billion, and the projected cost by the year 2030 is $30 billion (1978 dollars).1 In Canada, prevalence estimates in 1991 suggested that 252,600 (8.0%) of all Canadians aged 65 and over met the criteria for dementia.2 If the prevalence estimates remain constant, then the number of Canadians with dementia will rise to 592,000 by the year 2021.2 In a 1998 study by Hux et al., the annual societal cost of care per patient with Alzheimer's disease (AD) in Canada ranged from $9,451 for mild disease to $36,794 (1996 Canadian dollars) for severe disease.3

Various institution- and community-based studies have indicated that survival is significantly reduced by AD and vascular dementia (VaD).4-6 At present, the progressive course of dementia cannot be reversed,7,8 and prognostic data are therefore important in the management of this condition and in the allocation of resources.9 Several prognostic factors have been investigated: increasing age,9-13 male sex,6,9,10,13-15 functional disability (mobility),6,8-10,16-19 severity of dementia,4,5,8-11,14,15 age of onset,8,9,11,12,16 educational level,9,10,12,14,15 extrapyramidal signs (EPS)11,20-22 and comorbidity.1,5,8,14 Only age, sex and mobility have been shown consistently in the literature to be related to shorter survival, and since only mobility is modifiable, it is a vital prognostic factor in dementia.

Poor mobility is postulated to affect survival both by increasing the risk of falls and through secondary diseases related to immobility.8 Patients with AD are known to be at considerable risk for falls and fractures compared with non-demented persons of the same age. Fractures tend to immobilize patients even further. Immobility then places them at risk for other potentially lethal events, such as pulmonary embolus and aspiration pneumonia.8

Unfortunately, past studies that have identified the value of mobility as a predictor of survival in dementia are hampered by methodologic complications (Table 1).6,8-10,16-19 Many study populations consisted of subjects from geriatric and dementia clinics, psychiatric hospitals and nursing homes,8,16,17,19 often with over-representation of advanced cases. The aim of all previous studies has been to detect predictors of disease prognosis,6,8-10,16-19 and to our knowledge none has concentrated exclusively on investigating mobility. Most studies have restricted their scope to Alzheimer's disease,8,10,16-18 and only one recent study has investigated all dementias.9


TABLE 1
Review of studies with mobility as a prognostic indicator for survival in dementia

Author (year)

Size of study
(
n)

Years of
follow-up

Type of dementia

Definition of mobility

Measure of
association
(95% CI)

Knopman et al. (1988)17

101

2

Alzheimer's disease (AD)

Blessed Dementia Rating Scale OR = 2.2
(p = 0.03)
Walsh et al. (1990)8

126

6

AD

Wandering and falling RR = 3.1
(1.4-6.6)
van Dijk et al. (1992)19

606

8

AD, Multi-infarct dementia (MID)

Stockton Geriatric Scale OR = 1.7
(p < 0.05)
Bracco et al. (1994)16

145

9

AD

Blessed Dementia Rating Scale HR = 2.11
(1.13-3.92)
Molsa et al. (1995)6

333

14

AD, MID

Disability graded on the need of help in daily activities AD: RR = 1.15
(0.86-1.55)
MID: RR = 2.32
(1.39-3.88)
Heyman et al. (1996)10

1036

7

AD

Blessed Dementia Rating Scale HR = 1.09
(1.04-1.14)
Bowen et al. (1996)18

327

6.5

AD

Blessed Dementia Rating Scale OR = 2.7
(1.7-4.5)
Aguero-Torres et al. (1998)9

223

7

All dementia

Katz Activities of Daily Living Scale HR = 1.20
(1.09-1.33)
CI = confidence interval; OR = odds ratio; RR = relative risk; HR = hazard rate

   

Finally, and most importantly, the definition of mobility has been poorly captured in almost all studies. A wide range of proxies for mobility, such as the Katz Activities of Daily Living (ADL) Scale,9,23 the Blessed Dementia Rating Scale10,16-19,24 and the Stockton Geriatric Rating Scale,19,25 have been used. This is also the case outside the field of dementia.26-31 None of these investigations, however, has brought together all of the important elements of mobility. An aggregation of these features that includes ADL, falls, walking, gait and motor system disorders would result in a powerful and instrumental definition of mobility. The combination of ADL measures and clinical variables would be unique in the study of mobility in dementia.

The high prevalence of dementia in older people, the rapid increase in the oldest sector of the population in industrialized countries and the lack of an effective treatment to reverse the disease underscore the need to identify factors related to favourable prognosis in dementia.9 The aim of this study, a two-year evaluation of 957 subjects with dementia, was to identify elements of mobility that predict survival in elderly patients with dementia.


Methods

Setting and Participants

The study involved subjects from the Canadian Study of Health and Aging - Part 1 (CSHA-1). The CSHA-1 was a survey conducted across Canada in 1991-1992 to estimate the prevalence of dementia and its subtypes; details of the study methods have been reported elsewhere.2 In brief, the survey included a representative sample of people aged 65 and over from community and institutional settings in all 10 provinces. Thirty-six cities and their surrounding rural areas were selected by cluster sampling;32 roughly 60% of Canadians 65 and over lived in the sample areas.2

The community sample was obtained from the databases of the provincial health insurance plans, except in Ontario, where enumeration records were used. Of the 19,398 people on the community sample lists, 9,008 were eligible and agreed to participate.2 The institutional sample comprised subjects in nursing homes, chronic care facilities and collective dwellings such as convents. It consisted of 1,817 subjects, of whom 1,255 were eligible and agreed to participate.2

For community participants, the survey had a two-phase design. In the first phase, individuals were interviewed in their homes after written consent had been obtained. The Older Americans Resources and Services ADL Scale was completed,33 and a Modified Mini-Mental State (3MS) examination was performed.34 Individuals scoring 77 or less on the 3MS (maximum score = 100) were identified as potentially cognitively impaired and were invited to proceed to the second phase of the study, which involved a clinical assessment.32 A random sample of those who scored higher than 77 was also invited to participate in the second phase in order to estimate the false-negative rate of the 3MS. Institutionalized subjects were evaluated in one phase, which included both the interview and the clinical assessment.


The clinical examination assessed the presence of cognitive impairment and provided a differential diagnosis of dementia.2 The diagnostic criteria for dementia followed the third revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R).35 A diagnosis of Alzheimer's disease was based on the criteria of the National Institute of Neurological and Communicative Disorders and Stroke, and the Alzheimer's Disease and Related Disorders Association.36 A draft of the 10th revision of the International Classification of Diseases was used to define subcategories of vascular and other dementias.37

The examination was in four parts. Clinical team members were unaware of the 3MS score obtained at the screening interview. First, a nurse administered the 3MS examination; tested hearing, vision and vital signs; recorded height, weight and medication use; and obtained the subject's cognitive and family history from a relative, using section H of the Cambridge Mental Disorders of the Elderly Examination (CAMDEX).2,38 Second, a neuropsychologist evaluated psychometric test results in conjunction with the results of the CAMDEX and the 3MS examination administered by the nurse. Third, a physician reviewed the information collected by the nurse and examined the patient, performing a mental status assessment as well as physical and neurologic examinations. Finally, subjects suspected of having dementia or delirium were sent for hematologic and biochemical tests.2

Final diagnostic categories included no cognitive impairment (NCI), cognitive impairment without dementia (CI) and four general types of dementia: AD (probable and possible Alzheimer's disease), VaD (vascular dementia), other dementia and unclassified dementia.32 Other dementias included those resulting from Huntington's chorea, Creutzfeldt-Jakob disease, Parkinson's disease, Pick's disease and head injury. The final diagnosis for each participant was reached in a consensus conference that integrated all available data on a particular individual and included the physician, study nurse, psychometrician and neuropsychologist who had examined the patient.

Consistency of diagnosis was assessed in two ways. First, there was a comparison of the diagnosis given with that obtained from a computer algorithm. Second, for 210 cases, a review of clinical chart data by a study physician from another centre was performed. The agreement between the computer classification and the final diagnosis was 97.6% for the distinction between dementia and non-dementia and 97.5% for the distinction between probable AD and other types of dementias.32 The kappa index of agreement between the study diagnosis and the review diagnosis by the second physician was 0.70 for the classification of NCI, CI, AD and other dementias.2

The present investigation followed a cohort of 957 subjects: 272 community subjects with a diagnosis of AD and 77 with a diagnosis of VaD; and, of institutionalized subjects, 477 with AD and 131 with VaD. Subjects with a diagnosis of "other" and "unclassified" dementia were excluded from the study.

In 1993-1994, two years after the CSHA-1, the 18 study centres conducted a field study, known as the Maintaining Contact Study (MCS), to re-contact CSHA-1 participants. Basic health status, including vital status, was assessed at that time. The CSHA-2 study then followed in 1996-1997, and re-evaluated the individuals involved in CSHA-1. The vital status of each individual in the CSHA-1 cohort was assessed using MCS data from two years after the clinical examination in conjunction with CSHA-2 data. Information on the date of death was obtained through next-of-kin interviews and confirmed with the Provincial Registrar of Births and Deaths. At this time, 267 subjects with AD and 81 subjects with VaD had died.


Prognostic Factors

Mobility

The main predictor of interest in this study was mobility. Items and measures were selected from the clinical examination phase of the CSHA-1 based on five broad categories: ADL, walking, falls, motor system disease and gait. These elements formed an operational definition of mobility.4,8-10,16-19,26,28,30

The ADL category was represented by difficulties in dressing. This item was part of the CAMDEX section of the clinical assessment.38 The CAMDEX interview was conducted by a study nurse with a relative, friend or caregiver who may or may not have been living with the subject. Nurses underwent a one-week training program in administration of the CAMDEX, which is both a valid and reliable measure.2,38 Subjects were categorized as having, or not having, difficulties in dressing, which ranged from misaligned buttons to complete inability to dress themselves. Information on this variable was available for 926 of the 957 subjects. Walking and ability to get about were also assessed by the CAMDEX. Participants were classified as having, or not having, difficulties in getting about. Data on this variable were missing for 101 subjects.

Information on previous falls was obtained by the physicians through a clinical history involving the patient and/or family member. The physicians' clinical and physical assessments were standardized using training materials such as manuals and videotapes.2 Information on history of falls was unavailable for 66 subjects. Motor system strength and gait were assessed by physical examination. These variables were categorized as normal, abnormal or could not be examined. Gait pattern and motor strength could not be examined in 34% and 13% of individuals respectively.


Covariates

Because other factors, for example age and comorbidity, are also associated with mobility, they are classically defined covariates of the mobility-survival association and were adjusted for in the analyses. Sociodemographic covariates were collected during the clinical assessment phase of the study. Data for age, sex and residence were complete. Information on marital status was missing for eight individuals, and educational data were available for 795 of the 957 participants.

Further information was gathered on disease-related covariates, including dementia type, duration and severity, and cognitive function (3MS). Subjects were categorized as having a diagnosis of AD or VaD, and dementia severity was graded by physicians as mild, moderate or severe; severity data were missing for 11 subjects. The duration of dementia was taken as the age of onset of first memory symptoms (CAMDEX data) subtracted from age at clinical assessment. This information was available for 861 of the 957 participants. The 3MS examination to evaluate cognitive function was conducted during the clinical assessment phase, and the score was summarized into four categories (0-29, 30-49, 50-69 and 70-100); scores were missing for 98 subjects.

Data on comorbid conditions were collected using physician clinical histories and the CAMDEX. Subjects were categorized as having a positive or negative history of heart attack, stroke, Parkinson's disease and respiratory difficulties (asthma, bronchitis). For 39 subjects, data were missing on heart attack; for 121, on respiratory problems; for 47, on stroke; and for 23, on Parkinson's disease.


Statistical Methods

Descriptive univariate analyses and comparisons among all prognostic variables were conducted using simple distributions, Pearson correlations and chi-squared tests.39 Bivariate comparisons between individual predictors and outcome status were made using chi-squared tests.39 The effect of prognostic factors on survival was then further evaluated by unconditional logistic regression modelling.40 This technique provided the best fitting and most parsimonious models to describe the relation between the dichotomous survival outcome and the set of independent mobility and covariate variables.40 Age, sex, education and type of dementia were substantively included in the models.

Each mobility variable was then modelled independently of the others. Possible prognostic covariates were entered successively. The four variables related to comorbid conditions were entered as a group. This modelling approach was used for the analysis of all demented subjects and for separate analyses of community and institution dwellers. Regression was performed using the indicator method to account for missing data:41-43 for each variable with missing values a missing-value indicator was created,41,42 which took the value 1 wherever the original variable was missing and 0 elsewhere.41,42 Statistical analyses were conducted using the SAS statistical software package.44

Mobility and several covariates were investigated as potential predictors of survival. Age was entered in the models as a continuous variable. Sex (male or female), residence (community or institution), education (< 8 years or 8+ years), dementia type (AD or VaD), difficulty dressing (yes or no), difficulty getting about (yes or no), history of falls (yes or no) and all comorbidity variables (yes or no) were evaluated as dichotomous. Finally, disease duration (< 2, 3-5, 6+ years), severity (mild, moderate, severe), 3MS score (0-29, 30-49, 50-69 and 70-100), gait (normal, abnormal, could not be examined) and motor strength (normal, abnormal, could not be examined) were evaluated as categorical variables.


Results

General Characteristics

Of the 957 study subjects, 749 had a diagnosis of AD and 208 of VaD. Mean age at clinical examination was 85.0 (standard deviation = 7.1) years. Table 2 lists the principal baseline characteristics of the sample, and Table 3 summarizes the baseline mobility and comorbidity data.

In further unadjusted analyses, several sociodemographic characteristics varied significantly between community and institution dwellers. Subjects living in institutions were older than subjects in the community (p = 0.005) and included a higher proportion of females (p < 0.001) and of severe cases of dementia (p < 0.001). However, no significant differences were observed in the proportion of more highly educated participants (p = 0.265) or in the proportion of AD versus VaD dementia (p = 0.852) as a function of residence.

The unadjusted proportion of individuals with difficulties in dressing and getting about differed significantly with respect to residence, as did the unadjusted proportion of subjects with past falls, gait problems and strength difficulties (all p < 0.001). A history of stroke and Parkinson's disease was found to be more common in institutionalized subjects (p = 0.003 and p = 0.050 respectively), whereas no significant differences in a history of heart attack (= 0.444) or respiratory problems (= 0.150) were observed between community and institution residence.

Correlation analysis of sociodemographic, mobility and comorbidity variables revealed a high Pearson correlation coefficient of 0.756 (< 0.001) between disease severity and 3MS score. Because of a high occurrence of missing data for 3MS (10.2%) as compared with disease severity (1.1%), the 3MS variable was excluded from further analysis. Replacing severity with 3MS in the analyses yielded similar results.


Predictors of Survival

Unadjusted bivariate comparisons between individual predictors and outcome status revealed that survivors were significantly younger (< 0.001) and were more likely to be female (= 0.024), to live in the community (< 0.001) and to have a milder dementia (< 0.001) than those who died (Table 2). There was no significant difference between survivors and deceased in educational level (= 0.704), duration of disease (= 0.067) or type of dementia (= 0.382). Evaluation of individual mobility variables indicated that survivors were less likely to have a history of falls (< 0.001), difficulties in dressing (< 0.001), difficulties in getting about (< 0.001), gait problems (< 0.001) and strength problems (< 0.001) (Table3). There were no significant differences in comorbidity characteristics, including the proportion of participants with histories of stroke (p = 0.060), respiratory problems (p = 0.231) or Parkinson's disease (= 0.082). However, a history of previous heart attack was found to be less likely in survivors after two years of follow-up (= 0.047).

 


TABLE 2
Baseline demographic and clinical characteristics of the study population:
percent distribution of variables

Baseline characteristics

All subjects
n = 957

Subjects by vital status at two-year follow-up

Alive
n = 609

Dead
n = 348

p valuea

Age (years) 65-74

 7%

 8%

 3%

< 0.001<

75-84

36%

38%

34%

85+

57%

54%

63%

Sex Male

30%

27%

34%

0.024

Female

70%

73%

66%

Residence Community

36%

44%

24%

< 0.001<

Institution

64%

56%

76%

Marital statusb Married

25%

24%

27%

0.237

Single, divorced, widowed

75%

76%

73%

Education (years)b Elementary (0-7)

55%

55%

54%

0.703

Higher (8+)

45%

45%

46%

Dementia type Alzheimer's disease

78%

79%

77%

0.382

Vascular dementia

22%

21%

23%

Duration of disease (years)b 0-2

30%

31%

27%

0.067

3-5

40%

38%

46%

6+

30%

31%

27%

Severity of dementiab Mild

22%

25%

15%

< 0.001<

Moderate

38%

41%

35%

Severe

40%

34%

50%

3MS scoreb 0-29

36%

31%

46%

< 0.001<

30-49

23%

22%

26%

50-69

30%

34%

22%

70-100

11%

13%

 6%

a Crude (unadjusted) c2 test
b These variables have some missing values, as explained in the Methods section.

TABLE 3
Baseline mobility and comorbidity characteristics of the study population:
percent distribution of variables

Baseline characteristics

All subjects
n = 957

Subjects by vital status at two-year follow-up

Alive
n = 609

Dead
n = 348

p valuea

Mobility
Difficulty dressingb No

39%

48%

24%

< 0.001

Yes

61%

52%

76%

Difficulty getting aboutb No

33%

39%

22%

< 0.001

Yes

67%

61%

78%

History of fallsb No

64%

68%

55%

< 0.001

Yes

36%

32%

45%

Gait Normal

26%

32%

15%

< 0.001

Abnormal

40%

40%

39%

Could not be examined

34%

28%

46%

Motor system strength Normal

56%

62%

46%

< 0.001

Abnormal

31%

27%

37%

Could not be examined

13%

11%

17%

Comorbidity
History of heart attackb No

86%

88%

83%

0.046

Yes

14%

12%

17%

History of respiratory  problemsb No

82%

83%

80%

0.231

Yes

18%

17%

20%

History of strokeb No

69%

71%

65%

0.060

Yes

31%

29%

35%

History of Parkinson's diseaseb No

96%

94%

97%

0.078

Yes

 4%

 6%

 3%

a Crude (unadjusted) c2 test
b These variables have some missing values, as explained in the Methods section.

   

Regression Modelling

The effect of mobility and other prognostic factors on survival was further evaluated for all subjects by unconditional logistic regression modelling (Table 4). Models 1 through 5 provided the odds ratio (OR) and 95% confidence intervals (95% CI) for each mobility variable adjusted for age, sex, residence, education, dementia type, dementia severity and all comorbid conditions. In all five models adjusted for covariates, individuals with any type of mobility difficulty were at significantly greater risk of death at two-year follow-up. The adjusted models further indicated that individuals who could not be examined for gait abnormalities were also at significantly increased risk of a poor outcome. Finally, the adjusted associations between death at two-year follow-up and older age, male sex and institutional residence were all statistically significant, confirming the results of the crude bivariate analyses.


Other baseline characteristics, including educational level, dementia type, dementia severity and all comorbid conditions except for heart attack history were not significantly related to survival after adjustment for all other variables. When duration of dementia was entered into all five models it was not significantly related to survival, and because of the high occurrence of missing values (10.0%), it was removed from further analysis. All five mobility variables were found to be significant (p = 0.002) when entered as a group into a model containing all other baseline variables. Assessment of standard errors in this model revealed no collinearity issues.40

Similar logistic regression models were constructed, separately, for community and institution dwellers. In the community sample, only older age, male sex, difficulty getting about and abnormal gait were significant predictors of shorter survival after adjustment for covariates (Table 5). Severity of dementia was only a significant predictor when severe cases were compared with mild cases, and VaD dementia was found to significantly predict poor survival in the three models that included the variables of strength, falls and difficulty getting about. In the institution sample, older age, male sex, difficulties dressing, difficulties getting about and abnormal motor strength were the strongest predictors of decreased survival (Table 6). Individuals who could not be examined for gait abnormalities were found to be at significantly increased risk of a poor outcome.

 


TABLE 4
Predictors of death in dementia after two years of follow-up:
unconditional logistic regression modelling of all subjects (
n = 957)

Predictor

Model 1

Model 2

Model 3

Model 4

Model 5

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Age (years)

1.05

1.03-1.07c

1.05

1.03-1.08c

1.05

 1.03-1.07c

1.05

1.03-1.07c

1.05

1.03-1.08c

Male vs female

1.79

1.29-2.49c

1.79

1.29-2.48c

1.78

1.28-2.46c

1.82

1.31-2.52c

1.78

1.29-2.47c

Residence                    
 Institution vs community

1.57

1.08-2.26a

1.87

1.32-2.66c

1.86

1.31-2.65c

1.71

1.19-2.45b

1.82

1.27-2.59b

Education                    
 Higher vs elementary

1.05

0.76-1.43

1.06

0.78-1.45

1.08

0.79-1.48

1.08

0.79-1.48

1.08

0.79-1.48

Dementia type                    
 Vascular vs Alzheimer's

1.10

0.73-1.66

1.15

0.76-1.73

1.14

0.76-1.72

1.10

0.73-1.65

1.05

0.69-1.61

Severity of dementia                    
 Moderate vs mild

1.01

0.66-1.54

1.20

0.79-1.82

1.17

0.78-1.76

1.18

0.78-1.78

1.17

0.78-1.76

 Severe vs mild

1.12

0.68-1.83

1.44

0.89-2.31

1.52

0.96-2.42

1.37

0.86-2.20

1.45

0.91-2.33

Mobility                    
 Difficulty dressing

2.08

1.41-3.07c

               
 Difficulty getting about    

1.69

1.18-2.40b

           
 History of falls        

1.43

1.05-1.94a

       
 Gait (vs normal)                    
  Abnormal            

1.61

1.08-2.40a

   
  Could not be examined            

2.01

1.27-3.16b

   
 Motor strength (vs normal)                    
  Abnormal                

1.51

1.07-2.15a

  Could not be examined                

1.36

0.85-2.17

Comorbidities                    
 Heart attack

1.57

1.05-2.35a

1.59

1.06-2.38a

1.55

1.04-2.31a

1.56

1.05-2.33a

1.61

1.08-2.40a

 Respiratory problems

1.27

0.85-1.89

1.17

0.79-1.74

1.23

0.83-1.83

1.17

0.79-1.74

1.19

0.80-1.77

 Stroke

1.08

0.75-1.56

1.04

0.72-1.51

1.04

0.72-1.51

1.01

0.70-1.46

1.02

0.70-1.48

 Parkinson's disease

1.46

0.73-2.93

1.41

0.70-2.82

1.42

0.71-2.85

1.37

0.69-2.73

1.45

0.72-2.90

a 0.050 >= p >= 0.010
b 0.010 >= p >= 0.001
c p < 0.001

TABLE 5
Predictors of death in dementia after two years of follow-up:
logistic regression models of community dwellers (
n = 349)

Predictor

Model 1

Model 2

Model 3

Model 4

Model 5

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Age (years)

1.14

1.08-1.20c

1.14

1.08-1.21c

1.15

1.08-1.21c

1.14

1.07-1.20c

1.15

1.09-1.21c

Male vs female

2.54

1.40-4.61b

2.48

1.37-4.50b

2.66

1.46-4.84b

2.69

1.46-4.95b

2.55

1.40-4.64b

Education                    
 Higher vs elementary

0.86

0.48-1.55

0.86

0.48-1.55

0.89

0.50-1.60

0.84

0.46-1.51

0.87

0.49-1.57

Dementia type                    
 Vascular vs Alzheimer's

2.05

0.95-4.42

2.20

1.04-4.67a

2.18

1.03-4.60a

1.99

0.93-4.27

2.20

1.01-4.80a

Severity of dementia                    
 Moderate vs mild

1.21

0.65-2.25

1.31

0.72-2.40

1.29

0.71-2.34

1.36

0.75-2.46

1.37

0.76-2.49

 Severe vs mild

3.26

1.13-9.40a

3.83

1.43-10.2b

4.00

1.52-10.5b

3.89

1.47-10.3b

3.81

1.44-10.1b

Mobility                    
 Difficulty dressing

1.67

0.85-3.28

               
 Difficulty getting about    

1.89

1.02-3.49a

           
 History of falls        

1.77

0.96-3.26

       
 Gait (vs normal)                    
  Abnormal            

1.91

1.01-3.60a

   
  Could not be examined            

1.98

0.66-5.93

   
 Motor strength (vs normal)                    
  Abnormal                

1.24

0.60-2.53

  Could not be examined                

2.24

0.41-12.2

Comorbidities                    
 Heart attack

1.62

0.78-3.38

1.50

0.71-3.15

1.56

0.76-3.28

1.50

0.71-3.14

1.61

0.77-3.34

 Respiratory problems

0.98

0.49-1.98

1.01

0.50-2.04

1.01

0.50-2.05

0.93

0.46-1.88

0.99

0.49-1.98

 Stroke

0.73

0.35-1.55

0.70

0.33-1.46

0.71

0.34-1.48

0.68

0.33-1.43

0.70

0.33-1.47

 Parkinson's disease

2.73

0.53-14.1

3.22

0.63-16.6

3.26

0.64-16.5

2.39

0.45-12.6

3.01

0.59-15.4

a 0.050 >= p >= 0.010
b 0.010 >= p >= 0.001
c p < 0.001

TABLE 6
Predictors of death in dementia after two years of follow-up:
logistic regression models of institutionalized subjects (
n = 608)

Predictor

Model 1

Model 2

Model 3

Model 4

Model 5

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Age (years)

1.03

1.01-1.06b

1.04

1.01-1.06b

1.03

1.01-1.06a

1.03

1.01-1.05a

1.03

1.01-1.06b

Male vs female

1.56

1.04-2.33a

1.58

1.06-2.36a

1.55

1.04-2.33a

1.59

1.06-2.37a

1.56

1.04-2.33a

Education                    
 Higher vs elementary

1.18

0.80-1.73

1.17

0.79-1.72

1.20

0.82-1.77

1.22

0.83-1.80

1.22

0.83-1.80

Dementia type                    
 Vascular vs Alzheimer's

0.82

0.50-1.36

0.81

0.49-1.34

0.82

0.49-1.36

0.81

0.49-1.34

0.74

0.44-1.23

Severity of dementia                    
 Moderate vs mild

0.82

0.44-1.55

0.96

0.52-1.81

0.93

0.50-1.73

0.92

0.49-1.72

0.91

0.49-1.70

 Severe vs mild

0.82

0.43-1.57

1.04

0.56-1.94

1.09

0.59-2.02

0.98

0.53-1.83

1.02

0.55-1.90

Mobility                    
 Difficulty dressing

2.12

1.28-3.51b

               
 Difficulty getting about    

1.59

1.02-2.50a

           
 History of falls        

1.38

0.97-1.98

       
 Gait (vs normal)                    
  Abnormal            

1.29

0.74-2.23

   
  Could not be examined            

1.75

1.00-3.05a

   
 Motor strength (vs normal)                    
  Abnormal                

1.65

1.09-2.49a

  Could not be examined                

1.38

0.84-2.27

Comorbidities                    
 Heart attack

1.54

0.93-2.53

1.64

0.99-2.71

1.54

0.94-2.54

1.57

0.95-2.59

1.63

0.99-2.70

 Respiratory problems

1.47

0.88-2.46

1.25

0.75-2.07

1.39

0.84-2.31

1.33

0.81-2.21

1.30

0.79-2.16

 Stroke

1.25

0.81-1.93

1.24

0.81-1.92

1.23

0.80-1.91

1.21

0.78-1.87

1.18

0.76-1.82

 Parkinson's disease

1.45

0.67-3.14

1.36

0.63-2.94

1.39

0.64-2.99

1.40

0.65-3.01

1.44

0.67-3.10

a 0.050 >= p >= 0.010
b 0.010 >= p >= 0.001
c p < 0.001


   

Discussion

Summary of Results

All elements of mobility were found to be significantly related to decreased survival, both before and after adjustment for other covariates. Inability to perform the examination to assess gait function also strongly predicted shorter survival. Older age and male sex consistently predicted shorter survival among all subjects and in separate analyses of institution and community dwellers. Education, dementia type, dementia duration and dementia severity were not significantly related to survival among all subjects, although VaD and severe dementia predicted poor survival in community dwellers alone. Finally, only one comorbid condition, heart attack history, was a significant predictor of death at two-year follow-up.

Characteristics and Limitations

This study had three main limitations. First, the cohort of dementia subjects was derived from a population-based survey and therefore included only prevalent cases of dementia. Cases with very rapid progression of disease were less likely to be included. Second, despite the large initial sample size, the separate analyses for community and institutional residence may have had limited power, and those results not found to be statistically significant need to be interpreted with caution. Third, the cohort may also have had insufficient power to detect a true difference in some variables that were uncommon in this population, such as individual comorbidity.

However, the sample included community and institution dwellers as well as AD and VaD cases, and the present findings are believed to be generalizable to prevalent dementia in a broad-based population. Information on mobility variables, covariates and vital status measures were accurately and precisely collected in order to minimize misclassification bias.2 Finally, stringent sampling procedures and assessment of all known covariates aided in the reduction of selection and confounding biases.2


Comparison with Literature

The present study, indicating that mobility is an important predictor of survival in elderly people with dementia, is consistent with results from previous studies that have evaluated functional disability in dementia.6,8-10,16-19 We observed that elements of mobility that included difficulty in dressing and getting about were important prognostic factors, confirming results from studies that have assessed these variables using ADL scales.6,9,10,16-19 A history of falls was also found to predict poor survival. To our knowledge, falls were examined only in one prior investigation, by Walsh et al.,8 which reported similar results in a hospital-based study of AD patients.


The role of abnormal gait, although predictive of poor outcome in this study, has been controversial in the literature. Studies on gait and EPS in Alzheimer's disease by Stern et al.22 and Lopez et al.21 differed as to the importance of EPS in predicting mortality. We found, however, that the inability to examine gait is more predictive of death than abnormal gait itself. This was not remarked upon in previous studies, but may have been due to subjects' inability to stand up for the examination and may have been a marker of their general status45.

Motor strength was strongly related to survival, but its role was never examined in past investigations. Studies outside the field of dementia have indicated the importance of motor strength as a component of mobility.26-31 The closest proxy to motor strength investigated in the dementia literature is cachexia, which was shown both by Evans et al.46 and Nielsen et al.47 to be associated with poor survival.

Sociodemographic factors, including older age and male sex, significantly predicted poor outcome in this study. These results are consistent with the majority of studies that have investigated these variables.4,6,9-11,13-15,18,19 Furthermore, we observed that participants residing in institutions were at higher risk of death at two-year follow-up than community dwellers. Only Jagger et al.14 have previously analyzed this relation, and they found similar results. Educational level was not significantly related to survival in our study. This confirmed the results of four previous papers that examined education in Alzheimer's disease,10,12,16,18 but not those of Stern et al.15 Moreover, Hier et al.12 demonstrated a significant relation between lower educational attainment and survival in VaD. Our findings may be attributable to the limited sample of VaD patients in our study.


We observed that dementia severity is not predictive of poor outcome in all subjects, although severe dementia was found to be significantly related to survival in community dwellers. A positive relation between severity of disease and survival has been reported in some studies (mostly community-based8,10,14,17,18,46) but not in others (mostly institution-based4,11,16,48). These findings and our own may be related to the skewed distribution of disease severity in institutionalized individuals. A lack of mild cases in institutions may have resulted in insufficient power to detect a significant association between severity and survival. This hypothesis was supported in our analyses by the low proportion of mild cases of dementia in institutions as compared with the community.

Our finding of no significant relation between dementia type (AD or VaD) and survival was consistent with several studies.1,9,12,13 However, the community survey of Molsa et al.6 showed that VaD carried a less favourable survival prognosis than AD. This was also evident in our separate analysis of community participants. Possibly, in these older age groups the differences in disease-specific causes of death tend to be minimal,9 although it was unclear why this should not hold true for community participants.

Of the comorbid conditions assessed in this study, a history of heart attack was significantly associated with survival. This result is consistent with several previous investigations,5,6,14,18,19 although the two studies by van Dijk et al.5,19 both showed that stroke, respiratory disease and Parkinson's disease were also significant predictors of mortality. Our lack of such findings may be attributable to the low prevalence of some of these diseases and the limited sample size.


Implications and Conclusions

This study of dementia has shed light on the important elements of mobility that afford longer survival in patients with AD and VaD. Because the progressive course of dementia is not reversible, the results may be of value in providing prognostic information for families and health professionals. The elevated associations found here are important for clinicians to consider in discussions with patients and their families. Furthermore, because mobility is a modifiable factor, the study may help pave the way for targeting future interventions aimed at reducing or eliminating morbidity and mortality related to dementia.


Acknowledgements

The authors wish to thank Dr Gilles Paradis and Dr Michel Panisset for their invaluable comments on the manuscript, and Fabrice Rouah for his help in preparing the data for the analyses.

The data reported in this article were collected as part of the Canadian Study of Health and Aging. The core study was funded by the Seniors' Independence Research Program, through the National Health Research and Development Program (NHRDP) of Health Canada (project no 6606-3954-MC(S)). Additional funding was provided by Pfizer Canada Incorporated through the Medical Research Council/Pharmaceutical Manufacturers Association of Canada Health Activity Program, NHRDP (project no 6603-1417-302(R)), Bayer Incorporated and the British Columbia Health Research Foundation (projects no 38(93-2) and no 34(96-1)). The study was coordinated through the University of Ottawa and the Division of Aging and Seniors, Health Canada.


References

1. Martin DC, Miller JK, Kapoor W, et al. A controlled study of survival with dementia. Arch Neurol 1987;44:1122-6.

2. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J 1994;150:899-913.

3. Hux MJ, O'Brien BJ, Iskedjian M, et al. Relation between severity of Alzheimer's disease and costs of caring. Can Med Assoc J 1998;159:457-65.

4. Hébert M, Parlato V, Lese GB, et al. Survival in institutionalised patients: influence of dementia and loss of functional capacities. Arch Neurol 1995;52:469-76.

5. van Dijk PTM, Dippel DWJ, van der Meulen JHP, Habbema JDF. Comorbidity and its effect on mortality in nursing home patients with dementia. J Nerv Ment Dis 1996;184:180-7.

6. Molsa PK, Marttila RJ, Rinne UK. Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand 1995;91:159-64.

7. Kelley WN. Textbook of internal medicine. 2nd ed. Philadelphia: JB Lippincott, 1992.

8. Walsh JS, Welch HG, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 1990;113:429-34.

9. Aguero-Torres H, Fratiglioni L, Guo Z, et al. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 1998;46:444-52.

10. Heyman A, Peterson B, Fillenbaum G, Pieper C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part XIV: demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology 1996;46:656-60.

11. Stern Y, Tang MX, Albert MS, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA 1997;277:806-12.

12. Hier DB, Warach JD, Gorelick PB, Thomas J. Predictors of survival in clinically diagnosed Alzheimer's disease and multi-infarct dementia. Arch Neurol 1989;46:1213-6.

13. van Dijk PTM, Dippel DWJ, Habbema JDF. Survival of patients with dementia. J Am Geriatr Soc 1991;39:603-10.

14. Jagger C, Clarke M, Stone A. Predictors of survival with Alzheimer's disease. Psychol Med 1995;25:171-7.

15. Stern Y, Yang MX, Denaro J, Mayeux R. Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol 1995;37:590-5.

16. Bracco L, Gallato R, Grigoletto F, et al. Factors affecting course and survival in Alzheimer's disease. Arch Neurol 1994;51:1213-9.

17. Knopman DS, Kitto J, Deinard S, Heiring J. Longitudinal study of death and institutionalisation in patients with primary degenerative dementia. J Am Geriatr Soc 1988;36:108-12.

18. Bowen JD, Malter AD, Sheppard L, et al. Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 1996;47:433-9.

19. van Dijk PTM, van de Sande HJ, Dippel DWJ, Habbema JDF. The nature of excess mortality in nursing home patients with dementia. J Gerontol A Biol Sci Med Sci 1992;47:M28-M34.

20. Samson WN, van Duijn CM, Hop WCJ, Hofman A. Clinical features and mortality in patients with early-onset Alzheimer's disease. Eur Neurol 1996;36:103-6.

21. Lopez OL, Wisnieski SR, Becker JT, et al. Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol 1997;54:969-75.

22. Stern Y, Albert M, Brandt J, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analysis from the predictors study. Neurology 1994;44:2300-7.

23. Katz S, Ford AB, Moskowitz RW, et al. The index of ADL: a standardised measure of biological and psychosocial function. JAMA 1963;185:914-9.

24. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.

25. Mear B, Baker F. The Stockton Geriatric Scale. J Gerontol A Biol Sci Med Sci 1966;21:392-403.

26. Goldstein FC, Strasser DC, Woodard JL, Roberts VJ. Functional outcome of cognitively impaired hip fracture patients on a geriatric rehabilitation unit. J Am Geriatr Soc 1997;45:35-42.

27. Granger CV, Hamilton BB, Keith RA, et al. Advances in functional assessment for medical rehabilitation. In: Lewis CB, editor. Topics in Geriatric Rehabilitation. Baltimore: Aspen Publishing, 1986.

28. Lyles KW, Lammers JE, Shipp KM, et al. Functional and mobility impairments associated with Paget's disease of bone. J Am Geriatr Soc 1995;43:502-6.

29. Hogue CC, Studenski S, Duncan P. Assessing mobility: the first step in falls prevention. In: Tornquist EM, Fung SG, Champagne MT, et al, editors. Key aspects of recovery: improving nutrition, rest and mobility. New York: Springer, 1990:275-80.

30. Harada N, Chiu V, Damron-Rodriguez J, et al. Screening for balance and mobility impairment in elderly individuals living in residential care facilities. Phys Ther 1995;75:462-9.

31. Tinetti ME. Performance-oriented assessment of mobility problems in the elderly. J Am Geriatr Soc 1986;34:119-26.

32. Ebly EM, Parhad IM, Hogan DB, Fung TS. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology 1994;44:1593-1600.

33. Duke University Centre for the Study of Aging and Human Development. Multidimensional functional assessment: the OARS methodology. Durham (NC): Duke University, 1978.

34. Teng EL, Chui HC. The modified mini-mental state (3MS) examination. J Clin Psychiatry 1987;48:314-8.

35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington: American Psychiatric Association, 1987.

36. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.

37. Tenth revision of the International Classification of Diseases, 1987 draft of chapter V, categories F00-F99, mental, behavioural and developmental disorders. In: Clinical Descriptions and Diagnostic Guidelines (MNH/MEP/87.1 rev 1). Geneva: World Health Organization, 1987.

38. Roth M, Huppert FA, Tym E, et al. CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly. Cambridge (England): Cambridge University Press, 1988.

39. Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. Geneva: World Health Organization, 1991.

40. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley, 1989.

41. Miettinen OS. Theoretical epidemiology. New York: Wiley, 1985.

42. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 1995;142:1255-64.

43. Weinberg CR, Moledor ES, Umbach DM, Sandler DP. Imputation for exposure histories with gaps, under an excess relative risk model. Epidemiology 1996;7:490-7.

44. SAS Institute Inc. The SAS System 6.12. Cary (NC): SAS Institute Inc, 1996.

45. Marsden CD. Gait disorders in the elderly: pathophysiology of gait disorders. Course Notes 123 AAN. London: The National Hospital for Neurology and Neurosurgery, 1993.

46. Evans DA, Smith LA, Scherr PA, et al. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol 1991;134:403-12.

47. Nielsen H, Lolk A, Pedersen I, et al. The accuracy of early diagnosis and predictors of death in Alzheimer's disease and vascular dementia: a follow-up study. Acta Psychiatr Scand 1991;84:277-82.

48. Bianchetti A, Scuratti A, Zanetti O, et al. Predictors of mortality and institutionalisation in Alzheimer's disease patients one year after discharge from an Alzheimer's dementia unit. Dementia 1995;6:108-12.

Author References

Athanasios Tom Koutsavlis, Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital; and Department of Epidemiology and Biostatistics, McGill University; and Community Medicine Resident, Montreal-Centre Regional Public Health Department, Montreal, Quebec

Christina Wolfson, Director, Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital; and Associate Professor, Departments of Epidemiology and Biostatistics and of Medicine, McGill University, Montreal, Quebec

Correspondence: Dr Athanasios Tom Koutsavlis, Occupational and Environmental Health, Montreal-Centre Regional Public Health Department, 1301, rue Sherbrooke Est, Montréal (Québec)  H2L 1M3; Fax: (514) 528-2459; E-mail: kouts96@med.mcgill.ca

[Table of Contents] [Next]

Last Updated: 2002-10-04 Top